Rulonilimab 是一种针对PD-1的人源 IgG1 单克隆抗体，可以靶向、结合并抑制 PD-1 及其下游信号通路，具有潜在的免疫检查点抑制和抗肿瘤活性。
| 生物活性 | Rulonilimab is a humanIgG1monoclonal antibody againstPD-1that targets, binds and inhibitsPD-1and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com